Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging
Open Access
- 13 June 2015
- journal article
- review article
- Published by Springer Nature in European Radiology
- Vol. 26 (3) , 674-682
Abstract
Objectives Liver-specific MRI is a fast-growing field, with technological and protocol advancements providing more robust imaging and allowing a greater depth of information per examination. This article reports the evidence for, and expert thinking on, current challenges in liver-specific MRI, as discussed at the 7th International Forum for Liver MRI, which was held in Shanghai, China, in October 2013. Methods Topics discussed included the role of gadoxetic acid-enhanced MRI in the differentiation of focal nodular hyperplasia from hepatocellular adenoma and small hepatocellular carcinoma (HCC) from small intrahepatic cholangiocarcinoma (in patients with chronic liver disease), the differentiation of low-grade dysplastic nodule (DN) from pre-malignant high-grade DN and early HCC, and treatment planning and assessment of treatment response for patients with HCC and colorectal liver metastasis. Optimization of the gadoxetic acid-enhanced MRI protocol to gain robust arterial and hepatobiliary phase images was also discussed. Results and conclusions Gadoxetic acid-enhanced MRI demonstrates added value for the detection and characterization of focal liver lesions and shows promise in a number of new indications, including regional liver functional assessment and patient monitoring after therapy; however, more data are needed in some areas, and further developments are needed to translate cutting-edge techniques into clinical practice. Key Points • Liver-specific MRI is a fast-growing field, with many technological and protocol advancements. • Gadoxetic acid-enhanced MRI demonstrates value for detecting and characterizing focal liver lesions. • Gadoxetic acid-enhanced MRI shows promise in regional functional assessment and patient monitoring. • Further developments are needed to translate cutting-edge techniques into clinical practice.Keywords
This publication has 88 references indexed in Scilit:
- MR Imaging of Hepatocellular Adenomas and Differential Diagnosis DilemmaInternational Journal of Hepatology, 2013
- Feasibility study of in vivo MRI based dosimetric verification of proton end-of-range for liver cancer patientsRadiotherapy and Oncology, 2013
- Role of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced Magnetic Resonance Imaging in the Management of Hepatocellular Carcinoma: Consensus at the Symposium of the 48th Annual Meeting of the Liver Cancer Study Group of JapanOncology, 2013
- Optimization of the dynamic, Gd-EOB-DTPA-enhanced MRI of the liver: the effect of the injection rateActa Radiologica, 2012
- Hepatocellular carcinoma in a North American population: Does hepatobiliary MR imaging with Gd‐EOB‐DTPA improve sensitivity and confidence for diagnosis?Journal of Magnetic Resonance Imaging, 2012
- Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acidJournal of Magnetic Resonance Imaging, 2012
- Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCTJournal of Gastroenterology, 2012
- Typical and Atypical Imaging Findings of Intrahepatic Cholangiocarcinoma Using Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid–Enhanced Magnetic Resonance ImagingJournal of Computer Assisted Tomography, 2012
- Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumesRadiation Oncology, 2011
- Neoadjuvant Chemotherapy Before Liver Resection for Patients With Unresectable Liver Metastases From Colorectal CarcinomaJournal of Clinical Oncology, 2005